Claret Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.5M | Sell |
17,256
-77
| -0.4% | -$7.38K | 0.18% | 67 |
|
|
2025
Q4 | $1.67M | Sell |
17,333
-270
| -2% | -$26.2K | 0.19% | 66 |
|
|
2025
Q3 | $1.68M | Sell |
17,603
-1,031
| -6% | -$94.8K | 0.2% | 68 |
|
|
2025
Q2 | $1.62M | Sell |
18,634
-137
| -0.7% | -$11.6K | 0.21% | 63 |
|
|
2025
Q1 | $1.69M | Sell |
18,771
-1,412
| -7% | -$126K | 0.24% | 56 |
|
|
2024
Q4 | $1.61M | Sell |
20,183
-981
| -5% | -$84.9K | 0.25% | 56 |
|
|
2024
Q3 | $1.91M | Sell |
21,164
-717
| -3% | -$60.3K | 0.31% | 48 |
|
|
2024
Q2 | $1.72M | Sell |
21,881
-5,925
| -21% | -$486K | 0.31% | 48 |
|
|
2024
Q1 | $2.42M | Sell |
27,806
-1,900
| -6% | -$162K | 0.41% | 46 |
|
|
2023
Q4 | $2.45M | Sell |
29,706
-1,225
| -4% | -$93.4K | 0.44% | 41 |
|
|
2023
Q3 | $2.42M | Sell |
30,931
-479
| -2% | -$40.1K | 0.48% | 39 |
|
|
2023
Q2 | $2.77M | Sell |
31,410
-490
| -2% | -$42.2K | 0.54% | 37 |
|
|
2023
Q1 | $2.57M | Sell |
31,900
-860
| -3% | -$70.1K | 0.51% | 37 |
|
|
2022
Q4 | $2.55M | Sell |
32,760
-230
| -0.7% | -$18.6K | 0.56% | 33 |
|
|
2022
Q3 | $2.66M | Sell |
32,990
-165
| -0.5% | -$14.8K | 0.63% | 33 |
|
|
2022
Q2 | $2.98M | Sell |
33,155
-4,926
| -13% | -$499K | 0.64% | 33 |
|
|
2022
Q1 | $4.22M | Sell |
38,081
-10,542
| -22% | -$1.11M | 0.81% | 30 |
|
|
2021
Q4 | $5.03M | Sell |
48,623
-364
| -0.7% | -$42.1K | 0.93% | 26 |
|
|
2021
Q3 | $6.14M | Sell |
48,987
-658
| -1% | -$85.2K | 1.05% | 25 |
|
|
2021
Q2 | $6.16M | Sell |
49,645
-385
| -0.8% | -$48.3K | 1.01% | 27 |
|
|
2021
Q1 | $5.91M | Sell |
50,030
-155
| -0.3% | -$18.2K | 1.1% | 25 |
|
|
2020
Q4 | $5.88M | Sell |
50,185
-307
| -0.6% | -$33.8K | 1.16% | 26 |
|
|
2020
Q3 | $5.25M | Sell |
50,492
-176
| -0.3% | -$17.7K | 1.17% | 25 |
|
|
2020
Q2 | $4.65M | Sell |
50,668
-1,279
| -2% | -$123K | 1.1% | 24 |
|
|
2020
Q1 | $4.68M | Sell |
51,947
-1,197
| -2% | -$127K | 1.32% | 22 |
|
|
2019
Q4 | $6.03M | Buy |
53,144
+323
| +0.6% | +$35.4K | 1.16% | 24 |
|
|
2019
Q3 | $5.74M | Sell |
52,821
-1,101
| -2% | -$115K | 1.18% | 23 |
|
|
2019
Q2 | $5.25M | Sell |
53,922
-1,393
| -3% | -$127K | 1.09% | 22 |
|
|
2019
Q1 | $5.04M | Sell |
55,315
-265
| -0.5% | -$23.7K | 1% | 25 |
|
|
2018
Q4 | $5.06M | Sell |
55,580
-600
| -1% | -$56.1K | 1.12% | 24 |
|
|
2018
Q3 | $5.53M | Sell |
56,180
-3,734
| -6% | -$345K | 1.06% | 28 |
|
|
2018
Q2 | $5.13M | Sell |
59,914
-824
| -1% | -$68.8K | 1.05% | 30 |
|
|
2018
Q1 | $4.87M | Sell |
60,738
-667
| -1% | -$55K | 1.11% | 31 |
|
|
2017
Q4 | $4.96M | Buy |
+61,405
| New | +$4.92M | 1.08% | 31 |
|
Other funds holding MDT
VCM
VPM
Claret Asset Management's MDT Position: Q1 2026 in Review
Claret Asset Management reduced its Medtronic (MDT) stake by 0.44% in Q1 2026, selling an estimated $7.38K and leaving 17,256 shares worth $1.5M. The position accounts for 0.18% of the portfolio, ranked #67.
Claret Asset Management first reported a position in MDT in Q4 2017 and has held it in 34 quarters since. The position peaked at $6.16M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Claret Asset Management held 17,256 shares of Medtronic worth $1.5M as of Q1 2026.
- Claret Asset Management sold 77 Medtronic shares in Q1 2026, an estimated $7.38K.
- Medtronic made up 0.18% of Claret Asset Management's portfolio in Q1 2026, its #67 holding.
- Claret Asset Management first reported a position in Medtronic in Q4 2017 and has held it in 34 quarters since.
- Claret Asset Management's Medtronic position peaked at $6.16M in Q2 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.